Correlation Between Aerovate Therapeutics and Medigene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Medigene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Medigene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Medigene AG, you can compare the effects of market volatilities on Aerovate Therapeutics and Medigene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Medigene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Medigene.

Diversification Opportunities for Aerovate Therapeutics and Medigene

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Aerovate and Medigene is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Medigene AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigene AG and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Medigene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigene AG has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Medigene go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Medigene

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 4.9 times less return on investment than Medigene. But when comparing it to its historical volatility, Aerovate Therapeutics is 1.18 times less risky than Medigene. It trades about 0.02 of its potential returns per unit of risk. Medigene AG is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  155.00  in Medigene AG on September 14, 2024 and sell it today you would earn a total of  104.00  from holding Medigene AG or generate 67.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy72.49%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Medigene AG

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Medigene AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigene AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Medigene is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Aerovate Therapeutics and Medigene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Medigene

The main advantage of trading using opposite Aerovate Therapeutics and Medigene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Medigene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigene will offset losses from the drop in Medigene's long position.
The idea behind Aerovate Therapeutics and Medigene AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges